Supplementary Table 4

Supplementary Table 4. A) List of differentially expressed miRNAs and sncRNAs from DESeq2 analysis performed in stool from Cohort-CZ; B) List of sncRNAs differentially expressed in stool from both Cohort-IT and Cohort-CZ. C) Expression levels of the 19 DEmiRNAs in both cohorts stratified according to clinical data of the study population; D) Analysis of the clinical data between clusters of CRC patients obtained using the stool expression levels of 19 DEmiRNAs in the comparison between CRC and healthy subjects.

补充表4。A) 针对CZ队列（Cohort-CZ）的粪便样本开展DESeq2分析得到的差异表达微小RNA（miRNAs）与小非编码RNA（sncRNAs）列表；B) 同时在IT队列（Cohort-IT）与CZ队列（Cohort-CZ）的粪便样本中差异表达的小非编码RNA（sncRNAs）列表；C) 根据研究人群的临床数据进行分层后，两个队列中19种差异表达微小RNA（DEmiRNAs）的表达水平；D) 基于结直肠癌（CRC）与健康受试者的对照研究，利用19种差异表达微小RNA的粪便表达水平，对通过该19种RNA聚类得到的结直肠癌患者亚组间的临床数据进行分析。